Agenus Inc., a scientific-phase biotechnology organization, discovers and develops therapies to activate the body's immune procedure in opposition to most cancers and infections in America and internationally. It offers Retrocyte Display screen, an antibody expression platform for the identification of thoroughly human and humanized monoclonal anti